NewAmsterdam Pharma (NAMS) Treasury Shares (2022 - 2026)

NewAmsterdam Pharma has disclosed Treasury Shares across 5 years of filings, most recently posting $1.0 million for Q1 2026.

• Treasury Shares for Q1 2026 came in at $1.0 million, up 51.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (up 51.78% YoY), and the FY2025 annual result was $728283.0, up 409.28% from the prior year.
• Treasury Shares came in at $1.0 million for Q1 2026 at NewAmsterdam Pharma, up from $728283.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.0 million in Q1 2026 to a low of $143002.0 in Q4 2024.
• The 5-year median for Treasury Shares is $621105.2 (2022), against an average of $640210.7.
• Across the five-year window, Treasury Shares sank 76.51% in 2024 and soared 409.28% in 2025, its largest moves.
• NewAmsterdam Pharma's Treasury Shares stood at $621105.2 in 2022, then dropped by 1.98% to $608779.0 in 2023, then tumbled by 76.51% to $143002.0 in 2024, then jumped by 409.28% to $728283.0 in 2025, then soared by 38.34% to $1.0 million in 2026.
• The last three Treasury Shares figures came in at $1.0 million (Q1 2026), $728283.0 (Q4 2025), and $724908.0 (Q3 2025), per Business Quant data.